Literature DB >> 10710574

Using the Framingham model to predict heart disease in the United Kingdom: retrospective study.

S Ramachandran1, J M French, M P Vanderpump, P Croft, R H Neary.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10710574      PMCID： PMC27308          DOI： 10.1136/bmj.320.7236.676

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

2.  Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table.

Authors:  L E Ramsay; I U Haq; P R Jackson; W W Yeo; D M Pickin; J N Payne
Journal:  Lancet       Date:  1996-08-10       Impact factor: 79.321

3.  On the use of a logistic risk score in predicting risk of coronary heart disease.

Authors:  L E Chambless; A J Dobson; C C Patterson; B Raines
Journal:  Stat Med       Date:  1990-04       Impact factor: 2.373

4.  Long-term epidemiologic prediction of coronary disease. The Framingham experience.

Authors:  W B Kannel; M Larson
Journal:  Cardiology       Date:  1993       Impact factor: 1.869

5.  The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community.

Authors:  M P Vanderpump; W M Tunbridge; J M French; D Appleton; D Bates; F Clark; J Grimley Evans; H Rodgers; F Tunbridge; E T Young
Journal:  Thyroid       Date:  1996-06       Impact factor: 6.568
  5 in total
  23 in total

1.  New score is needed to predict risk of coronary heart disease.

Authors:  Peter Brindle; Tom Fahey; Shah Ebrahim
Journal:  BMJ       Date:  2002-05-18

2.  Framingham risk score is associated with femoral artery intima-media thickness in asymptomatic young adults (the Bogalusa heart study).

Authors:  Timir K Paul; Wei Chen; Sathanur R Srinivasan; Janet Rice; Ahmet Toprak; Jiang He; Gerald S Berenson
Journal:  Atherosclerosis       Date:  2010-10-20       Impact factor: 5.162

3.  Risk factor scoring for coronary heart disease.

Authors:  Hans-Werner Hense
Journal:  BMJ       Date:  2003-11-29

4.  Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation.

Authors:  K S Rabindranath; N R Anderson; R Gama; M R Holland
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

5.  Guidelines on preventing cardiovascular disease in clinical practice.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

6.  C-reactive protein for the prediction of cardiovascular risk: ready for prime-time?

Authors:  Daniel G Hackam; Steven L Shumak
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

Review 7.  Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review.

Authors:  P Brindle; A Beswick; T Fahey; S Ebrahim
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

8.  [Is there a relationship between the assessment of coronary risk on the Framingham and Sheffield tables and the sixth report of the Joint National Committee? Relationship between tables of coronary risk].

Authors:  L Viñas Cabrera; A Orti Llaveria; C Aguilar Martín; J M Pepió Villaubí; V Rubio Carque; M Miravalls Figuerola
Journal:  Aten Primaria       Date:  2003-03-31       Impact factor: 1.137

9.  Observed changes in the lipid profile and calculated coronary risk in patients given dietary advice in primary care.

Authors:  D Price; S Ramachandran; T Knight; P W Jones; R H Neary
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

10.  The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study.

Authors:  Peter M Brindle; Alex McConnachie; Mark N Upton; Carole L Hart; George Davey Smith; Graham C M Watt
Journal:  Br J Gen Pract       Date:  2005-11       Impact factor: 5.386
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.